X4 Pharmaceuticals, Inc. (XFOR)
2.77
-0.13
(-4.48%)
USD |
NASDAQ |
Oct 06, 16:00
2.78
+0.01
(+0.36%)
After-Hours: 20:00
X4 Pharmaceuticals Market Cap : 266.24M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 266.24M |
| October 05, 2026 | 278.73M |
| October 02, 2026 | 272.00M |
| October 01, 2026 | 272.00M |
| September 30, 2026 | 278.73M |
| September 29, 2026 | 278.73M |
| September 28, 2026 | 289.79M |
| September 25, 2026 | 289.30M |
| September 24, 2026 | 288.34M |
| September 23, 2026 | 298.92M |
| September 22, 2026 | 329.67M |
| September 21, 2026 | 335.92M |
| September 18, 2026 | 344.09M |
| September 17, 2026 | 336.40M |
| September 16, 2026 | 337.36M |
| September 15, 2026 | 347.93M |
| September 14, 2026 | 347.93M |
| September 11, 2026 | 336.40M |
| September 10, 2026 | 326.79M |
| September 09, 2026 | 346.01M |
| September 08, 2026 | 336.88M |
| September 04, 2026 | 388.30M |
| September 03, 2026 | 388.30M |
| September 02, 2026 | 388.30M |
| September 01, 2026 | 391.19M |
| Date | Value |
|---|---|
| August 31, 2026 | 388.30M |
| August 28, 2026 | 388.30M |
| August 27, 2026 | 406.56M |
| August 26, 2026 | 400.80M |
| August 25, 2026 | 399.84M |
| August 24, 2026 | 389.26M |
| August 21, 2026 | 388.30M |
| August 20, 2026 | 387.34M |
| August 19, 2026 | 399.84M |
| August 18, 2026 | 404.64M |
| August 17, 2026 | 413.29M |
| August 14, 2026 | 405.60M |
| August 13, 2026 | 412.33M |
| August 12, 2026 | 412.33M |
| August 11, 2026 | 411.37M |
| August 10, 2026 | 408.49M |
| August 07, 2026 | 445.97M |
| August 06, 2026 | 400.80M |
| August 05, 2026 | 398.88M |
| August 04, 2026 | 412.33M |
| August 03, 2026 | 385.77M |
| July 31, 2026 | 375.39M |
| July 30, 2026 | 377.28M |
| July 29, 2026 | 377.28M |
| July 28, 2026 | 370.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.828B |
| Arrowhead Pharmaceuticals, Inc. | 8.685B |
| Oncolytics Biotech, Inc. | 74.53M |
| Sangamo Therapeutics, Inc. | 58.00M |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| PS Ratio | 17.76 |
| Price to Book Value | 1.713 |
| Price | 2.77 |
| Earnings Yield | -43.09% |